Winning its second FDA approval this year, Boehringer Ingelheim's oral drug Jascayd is now cleared for use in the U.S. by ...

New research has identified the mechanism by which air pollution damages the lungs’ self-cleaning system, leaving us vulnerable to infection. In doing so, it has also identified a way to reverse that ...

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...

The FDA today approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of progressive pulmonary fibrosis (PPF ...

The Zephyr valve is a device that can improve breathing in people with emphysema, one of the two most common types of chronic obstructive pulmonary disease (COPD). The valve received approval by the ...

A mechanism in the body which typically helps a person heal from an injury, may actually be causing patients with idiopathic pulmonary fibrosis (IPF) to get worse, researchers at the National ...

A Brazilian study involving nearly 900 participants under the age of 40 reinforces the idea that premature lung aging is ...

Background Pulmonary function testing provides important insight regarding health; the vital capacity (VC) is so named because of its association with survival and longevity. Interpretation of ...

When a COVID survivor's lungs are permenantly damaged, it's not just medical decisions that decide whether they get a transplant The pandemic has led to a growing number of young people who need a ...

IPF is a life-threatening lung disease with no known cause. Over time, the lungs become scarred, making it harder to breathe. More than 250,000 Americans are living with IPF and other interstitial ...